News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merrion Pharmaceuticals, Inc. Cuts IPO Price Range to $6-$7 per ADS


10/30/2007 10:44:48 AM

Oct 30 (Reuters) - Merrion Pharmaceuticals Plc sharply cut its estimated initial public offering price range to $6 to $7 per American Depositary Share or 4.21 euros and 4.91 euros per ordinary share.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES